These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
464 related articles for article (PubMed ID: 20706113)
1. Coronary artery bypass graft surgery (CABG) for patients with diabetes and multivessel coronary artery disease: identifying patients who would benefit with CABG and understanding the potential mechanisms involved. Greason KL; Schaff HV Coron Artery Dis; 2010 Nov; 21(7):402-6. PubMed ID: 20706113 [TBL] [Abstract][Full Text] [Related]
2. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial. Daemen J; Kuck KH; Macaya C; LeGrand V; Vrolix M; Carrie D; Sheiban I; Suttorp MJ; Vranckx P; Rademaker T; Goedhart D; Schuijer M; Wittebols K; Macours N; Stoll HP; Serruys PW; J Am Coll Cardiol; 2008 Dec; 52(24):1957-67. PubMed ID: 19055986 [TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of studies comparing coronary artery bypass grafting with drug-eluting stenting in patients with diabetes mellitus and multivessel coronary artery disease. Lee MS; Yang T; Dhoot J; Iqbal Z; Liao H Am J Cardiol; 2010 Jun; 105(11):1540-4. PubMed ID: 20494658 [TBL] [Abstract][Full Text] [Related]
4. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. Hannan EL; Wu C; Walford G; Culliford AT; Gold JP; Smith CR; Higgins RS; Carlson RE; Jones RH N Engl J Med; 2008 Jan; 358(4):331-41. PubMed ID: 18216353 [TBL] [Abstract][Full Text] [Related]
5. Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents. Banning AP; Westaby S; Morice MC; Kappetein AP; Mohr FW; Berti S; Glauber M; Kellett MA; Kramer RS; Leadley K; Dawkins KD; Serruys PW J Am Coll Cardiol; 2010 Mar; 55(11):1067-75. PubMed ID: 20079596 [TBL] [Abstract][Full Text] [Related]
6. PCI versus CABG for multivessel coronary disease in diabetics. Tarantini G; Ramondo A; Napodano M; Favaretto E; Gardin A; Bilato C; Nesseris G; Tarzia V; Cademartiri F; Gerosa G; Iliceto S Catheter Cardiovasc Interv; 2009 Jan; 73(1):50-8. PubMed ID: 19089938 [TBL] [Abstract][Full Text] [Related]
7. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. Kapur A; Hall RJ; Malik IS; Qureshi AC; Butts J; de Belder M; Baumbach A; Angelini G; de Belder A; Oldroyd KG; Flather M; Roughton M; Nihoyannopoulos P; Bagger JP; Morgan K; Beatt KJ J Am Coll Cardiol; 2010 Feb; 55(5):432-40. PubMed ID: 20117456 [TBL] [Abstract][Full Text] [Related]
8. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease. Javaid A; Steinberg DH; Buch AN; Corso PJ; Boyce SW; Pinto Slottow TL; Roy PK; Hill P; Okabe T; Torguson R; Smith KA; Xue Z; Gevorkian N; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R Circulation; 2007 Sep; 116(11 Suppl):I200-6. PubMed ID: 17846304 [TBL] [Abstract][Full Text] [Related]
9. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials. Daemen J; Boersma E; Flather M; Booth J; Stables R; Rodriguez A; Rodriguez-Granillo G; Hueb WA; Lemos PA; Serruys PW Circulation; 2008 Sep; 118(11):1146-54. PubMed ID: 18725490 [TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry. Park DW; Kim YH; Yun SC; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Kim JJ; Choo SJ; Chung CH; Lee JW; Park SW; Park SJ J Am Coll Cardiol; 2010 Oct; 56(17):1366-75. PubMed ID: 20946993 [TBL] [Abstract][Full Text] [Related]
11. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution. Li Y; Zheng Z; Xu B; Zhang S; Li W; Gao R; Hu S Circulation; 2009 Apr; 119(15):2040-50. PubMed ID: 19349321 [TBL] [Abstract][Full Text] [Related]
12. Balancing benefit against risk in the choice of therapy for coronary artery disease. Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery. Morrison DA; Sacks J Minerva Cardioangiol; 2003 Oct; 51(5):585-97. PubMed ID: 14551526 [TBL] [Abstract][Full Text] [Related]
13. Coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stent implantation in patients with multivessel coronary disease. Yang ZK; Shen WF; Zhang RY; Kong Y; Zhang JS; Hu J; Zhang Q; Ding FH J Interv Cardiol; 2007 Feb; 20(1):10-6. PubMed ID: 17300391 [TBL] [Abstract][Full Text] [Related]
14. How to treat diabetic patients with multivesseal disease in the DES era. Pagnotta P; Cabbavale M; Briguori C Minerva Cardioangiol; 2006 Oct; 54(5):557-69. PubMed ID: 17019393 [TBL] [Abstract][Full Text] [Related]
15. Coronary revascularization in patients with type 2 diabetes and results of the BARI 2D trial. Sobel BE Coron Artery Dis; 2010 May; 21(3):189-98. PubMed ID: 20308880 [TBL] [Abstract][Full Text] [Related]
16. Multivessel coronary drug-eluting stenting alone in patients with significant ischemic mitral regurgitation: a 4-year follow up. Ho PC; Nguyen ME J Invasive Cardiol; 2008 Jan; 20(1):41-3. PubMed ID: 18174619 [TBL] [Abstract][Full Text] [Related]
17. Surgical revascularization is associated with improved long-term outcomes compared with percutaneous stenting in most subgroups of patients with multivessel coronary artery disease: results from the Intermountain Heart Registry. Bair TL; Muhlestein JB; May HT; Meredith KG; Horne BD; Pearson RR; Li Q; Jensen KR; Anderson JL; Lappé DL Circulation; 2007 Sep; 116(11 Suppl):I226-31. PubMed ID: 17846308 [TBL] [Abstract][Full Text] [Related]
18. Long-term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease. Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Choo SJ; Song H; Chung CH; Lee JW; Park SW; Park SJ Circulation; 2008 Apr; 117(16):2079-86. PubMed ID: 18413495 [TBL] [Abstract][Full Text] [Related]
19. Percutaneous coronary intervention or coronary artery bypass surgery for cardiogenic shock and multivessel coronary artery disease? Mehta RH; Lopes RD; Ballotta A; Frigiola A; Sketch MH; Bossone E; Bates ER Am Heart J; 2010 Jan; 159(1):141-7. PubMed ID: 20102880 [TBL] [Abstract][Full Text] [Related]
20. Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians. Rodés-Cabau J; Deblois J; Bertrand OF; Mohammadi S; Courtis J; Larose E; Dagenais F; Déry JP; Mathieu P; Rousseau M; Barbeau G; Baillot R; Gleeton O; Perron J; Nguyen CM; Roy L; Doyle D; De Larochellière R; Bogaty P; Voisine P Circulation; 2008 Dec; 118(23):2374-81. PubMed ID: 19029471 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]